TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

iBio Announces $26 Million Private Placement

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Ibio, Inc.
iBio Announces $26 Million Private Placement

iBio, Inc. (NASDAQ: IBIO) announced a private placement financing of approximately $26 million led by Frazier Life Sciences. The company will use proceeds to advance preclinical cardiometabolic programs including IBIO-610 and IBIO-600, extending cash runway into calendar 2028. The offering is expected to close on January 13, 2026.

Insights
BMLpJ   negative

Sold 37 million shares, reducing position by 6%


IBIO   positive

The company successfully secured $26 million in funding from quality institutional investors, which extends cash runway into 2028 and enables advancement of multiple preclinical programs. This demonstrates investor confidence and provides financial stability for continued R&D operations.